Inflammation and biliary tract injury

Current Opinion in Gastroenterology

Volumn 25, Issue 3, 2009, Pages 260-264

  Lu, Brandy R ^a   Mack, Cara L ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; Cholangiopathy; I B kinase complex; Innate like lymphocytes

Indexed keywords

TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; APOPTOSIS; BILE DUCT ATRESIA; BILE DUCT INJURY; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATORY DISEASE; INNATE IMMUNITY; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; REVIEW;

ANIMALS; AUTOIMMUNITY; BILE DUCTS; CHOLANGITIS; CYTOKINES; HUMANS; IMMUNITY, CELLULAR;

EID: 67651123302     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e328325aa10     Document Type: Review

References (34)

1. Lazaridis KN, Strazzabosco M, Larusso NF. The cholangiopathies: disorders of biliary epithelia. Gastroenterology 2004; 127:1565-1577.
2. Mack CL. The pathogenesis of biliary atresia: evidence for a virus-induced autoimmune disease. Semin Liver Dis 2007; 27:233-242. This review article focuses on the criteria necessary to define biliary atresia as an autoimmune disease and the evidence that presently exists to support this theory.
3. Harada K, Ohira S, Isse K, et al. Lipopolysaccharide activates nuclear factor-kappa β through toll-like receptors and related molecules in cultured biliary epithelial cells. Lab Invest 2003; 83:1657-1667. (Pubitemid 37421106)
4. Haruta I, Hashimoto E, Kato Y, et al. Lipoteichoic acid may affect the pathogenesis of bile duct damage in primary biliary cirrhosis. Autoimmunity 2006; 39:129-135. (Pubitemid 43675256)
5. Harada K, Nakanuma Y. Biliary innate immunity and cholangiopathy. Hepatol Res 2007; 37:S430-S437. Excellent review on the role of bile duct epithelial cells in triggering innate immunity. The authors present several experiments examining the role of endotoxin tolerance in cholangiopathies.
6. Yokoyama T, Komori A, Nakamura M, et al. Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappa β and -MAPK signaling pathways. Liver Int 2006; 26:467-476.
7. Chen XM, O'Hara SP, Nelson JB, et al. Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-kappa β. J Immunol 2005; 175:7447-7456.
8. Harada K, Ohba K, Ozaki S, et al. Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree. Hepatology 2004; 41:506-516.
9. Isse K, Harada K, Zen Y, et al. Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts. Hepatology 2005; 41:506-516. (Pubitemid 40289497)
10. Shimoda S, Harada K, Niiro H, et al. Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells. Hepatology 2008; 47:958-965. This article investigates the role that BECs play in the recruitment of mononuclear cells to the liver and possible mechanisms of injury in PBC.
11. Karrar A, Broome U, Södergern T, et al. Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis. Gastroenterology 2007; 132:1504-1514. Outstanding study demonstrating the role of antibodies from PSC patients in inducing innate immunity.
12. Harada K, Sato Y, Itatsu K, et al. Innate immune response to double-stranded RNA in biliary epithelial cells is associated with the pathogenesis of biliary atresia. Hepatology 2007; 46:1146-1154. This excellent original article demonstrates the role of TLR3 in the generation of antiviral responses and in the initiation of biliary epithelial apoptosis. The authors showed that double-stranded RNA could induce apoptosis in human biliary epithelial cells and put forth a mechanism for injury in biliary atresia.
13. Al-Masri AN, Flemming P, Rodeck B, et al. Expressions of the interferon-induced Mx proteins in biliary atresia. J Ped Surg 2006; 41:1139-1143. (Pubitemid 43870076)
14. Huang YH, Chou MH, Du YY, et al. Expression of toll-like receptors and type 1 interferon specific protein MxA in biliary atesia. Lab Invest 2007; 87:66-74.
15. Chuang YH, Lian ZX, Tsuenyeama K, et al. Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis. J Autoimmun 2006; 26:232-240.
16. Mattner J, Savage PB, Leung P, et al. Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe 2008; 3:304-315. The authors show that mice infected with alphaproteobacteria generate both PDC-E2 autoantibodies and T cell-mediated responses targeting bile ducts. Induction of disease required natural killer T cells. This article presents a novel mechanism involving natural killer T cells and molecular mimicry in murine PBC.
17. Chuang YH, Lian ZX, Yang GX, et al. Natural killer T cells exacerbate liver injury in a transforming growth factor b receptor II dominant negative mouse model of primary biliary cirrhosis. Hepatology 2008; 47:571-580. This study demonstrates the essential role of natural killer T cells in a mouse model of PBC.
18. Luedde T, Beraza N, Kotsikoris V, et al. Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 2007; 11:119-132. (Pubitemid 46209851)
19. Luedde T, Heinrichsdorff J, deLorenzi, et al. IKK1 and IKK2 cooperate to maintain bile duct integrity in the liver. PNAS 2008; 105:9733-9738. The investigators provide compelling information on the collaborative efforts of two IkB kinases to protect the biliary system from immune-mediated injury. This research is one of the most important publications within this review and implies that defects in IKK signaling may be implicated in human biliary diseases.
20. a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis. Gastroenterology 2008; 134:1482-1493. This fascinating work is aimed at determining how a deficiency in the chloridebicarbonate anion exchange transporter leads to an abnormal autoimmune response targeting biliary epithelia. This work is important in that it suggests that gene defects in anion transporters may predispose to the development of PBC.
21. + T cells as the effector cells responsible for bile duct destruction.
22. Mack CL, Tucker RM, Lu BR, et al. Cellular and humoral autoimmunity directed at bile duct epithelia in murine biliary atresia. Hepatology 2006; 44:1231-1239.
23. + lymphocytes in epithelia injury and autoimmunity in experimental biliary atresia. Gastroenterology 2007; 133:268-277. This study provides further convincing evidence for bile duct-targeted autoimmune responses and the importance of CD8+ T cells as effector cells involved in cholangiocyte injury in murine biliary atresia.
24. Selmi C, Zuin M, Gershwin ME. The unfinished business of primary biliary cirrhosis. J Hepatol 2008; 49:451-460. This article is an excellent review summarizing the disease course of PBC. The authors also provide an in depth look at novel pathogenic mechanisms in PBC.
25. Rigopoulou E, Davies ET, Bogdanos DP, et al. Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis. Liver Int 2007; 27:1226-1231. (Pubitemid 47543151)
26. Nakamura M, Kondo H, Mori T, et al. Antigp210 and anticentromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 2007; 45:118-127. (Pubitemid 46144371)
27. Allina J, Hu B, Sullivan DM, et al. T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun 2006; 27:232-241. (Pubitemid 46199127)
28. Berg CP, Stein GM, Keppler H, et al. Apoptosis-associated antigens recognized by autoantibodies in patients with the autoimmune liver disease primary biliary cirrhosis. Apoptosis 2008; 13:63-75.
29. Allina J, Stanca CM, Garber J, et al. Anti-CD16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis. J Autoimmun 2008; 30:238-245. (Pubitemid 351551504)
30. Pinyakong O, Habe H, Omori T. The unique aromatic catabolic genes in sphingomonads degrading polycyclic aromatic hydrocarbons. J Gen Appl Microbiol 2003; 49:1-19. (Pubitemid 36527148)
31. Amano K, Leung PS, Rieger R, et al. Chemical xenobiotics andmitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol 2005; 174:5874-5883. (Pubitemid 40593233)
32. Rieger R, Leung PS, Jeddeloh MR, et al. Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis. J Autoimmun 2006; 27:7-16. (Pubitemid 44279362)
33. Wakabyashi K, Lian ZX, Leung PSC, et al. Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology 2008; 48:531-540. This research provides convincing evidence of a xenobiotic as the initiating environmental trigger to the development of autoimmune cholangitis that mimics PBC.
34. Lu BR, Brindely SM, Tucker RM, et al. Serum autoantibodies reactive to alpha-enolase and vimentin in murine and human biliary atresia. Hepatology 2008; 48:412A.